If you are transitioning from another GLP-1 medication, the timeline may differ slightly
Furthermore, what if employers that offer self-insured plans to their employees and dependents follow suit
Cagrilintide, a long-acting amylin analogue, is frequently paired with incretins in study designs
16 The agencies pointed out 17 that commenters also noted that enabling States to more easily and, perhaps, therefore, more frequently, update their EHB-benchmark plans could result in expanded coverage for, among other things, maternity care, substance use disorder care, obesity care, and chronic disease management. So while most current EHB benchmark plans do not include coverage for anti-obesity medications, that could certainly change in the coming years
Request a chargeback if you were misled by false claims or did not receive the product
Clinical studies, such as the STEP trials for semaglutide, show that sustained use leads to greater weight loss and better maintenance of results